| Boost Your Portfolio's Health With These 4 Large-Cap Drug Stocks | 09/12 11:50 | zacks.com |
| This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday | 09/11 12:13 | benzinga.com |
| Novartis to License VYGR's Capsid for Gene Therapy in Neurology | 09/06 10:26 | zacks.com |
| Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts | 09/05 14:34 | benzinga.com |
| NVS or LLY: Which Is the Better Value Stock Right Now? | 09/04 12:45 | zacks.com |
| Novartis (NVS) Upgraded to Buy: Here's What You Should Know | 09/03 13:01 | zacks.com |
| Novartis' Cholesterol Drug Meets Primary Goals in Late-Stage Study | 08/29 10:51 | zacks.com |
| Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk | 08/28 01:15 | globenewswire.com |
| Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats | 08/26 10:21 | investors.com |
| Siemens Healthineers to buy Novartis unit for over $223 million, FT reports | 08/24 08:14 | reuters.com |